Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: A comparison using different radiometals

Journal of Liposome Research

Volumn 20, Issue 3, 2010, Pages 219-227

  Helbok, Anna ^a   Decristoforo, Clemens ^a   Dobrozemsky, Georg ^a   Rangger, Christine ^a   Diederen, Eric ^a   Stark, Brigitte ^b   Prassl, Ruth ^b   Von Guggenberg, Elisabeth ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Long circulatory; Nanotechnology; Targeting

Indexed keywords

GALLIUM 68; HISTIDINE; INDIUM 111; LIPID; LIPOSOME; LUTETIUM 177; NANOPARTICLE; PENTETIC ACID; RADIOISOTOPE; TECHNETIUM 99M;

ANALYTIC METHOD; ARTICLE; EVALUATION; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; LEWIS RAT; LIVER; MOLECULAR STABILITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; GALLIUM RADIOISOTOPES; INDIUM RADIOISOTOPES; ISOTOPE LABELING; LIPOSOMES; LUTETIUM; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; ORGANOTECHNETIUM COMPOUNDS; PENTETIC ACID; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, INBRED LEW; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955070397     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982100903311812     Document Type: Article

References (29)

1. Beaumier, P. L., Hwang, K. J., Slattery, J. T. (1983). Effect of liposome dose on the elimination of small unilamellar sphingomyelin/cholesterol vesicles from the circulation. Res Commun Chem Pathol Pharmacol 39:277-289.
2. Blume, G., Cevc, G. (1993). Molecular mechanism of the lipid vesicle longevity in vivo. Biochim Biophys Acta 1146:157-168.
3. Elbayoumi, T. A., Torchilin, V. P. (2006). Enhanced accumulation of long-circulating liposomes modifed with the nucleosome-specifc monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. Eur J Nucl Med Mol Imaging 33:1196-1205.
4. Fritzberg, A. R. (1987). Advances in 99mTc-labeling of antibodies. Nuklearmedizin 26:7-12.
5. Gabizon, A., Catane, R., Uziely, B., Kaufman, B., Safra, T., Cohen, R., et al. (1994). Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polethylene-glycol-coated liposomes. Cancer Res 54:987-992.
6. Goyal, P., Goyal, K., Kumar, S. G. V., Singh, A., Katare, O. P., Mishra, D. N. (2005). Liposomal drug delivery systems\clinical applications. Acta Pharm 55:1-25.
7. Harivardhan Reddy, L., Sharma, R. K., Chuttani, K., Mishra, A. K., Murthy, R. S. (2005). Infuence of administration route on tumor uptake and biodistribution of etoposide-loaded solid lipid nan-oparticles in Dalton's lymphoma tumor-bearing mice. J Contr Rel 105:185-198.
8. Immordino, M. L., Dosio, F., Cattel, L. (2006). Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential. Int J Nanomed 1:297-315.
9. 3-octreotate: labeling with β-emitting radionuclides for the preparation of potential therapeutic radiopharmaceuticals. J Radioanal Nucl Chem 273:689-694.
10. Lasic, D. D., Papahadjopoulos, D. (1995). Liposomes revisited. Science 267:1275-1276.
11. Laverman, P., Boerman, O. C., Oyen, W. J., Dams, E. T., Storm, G., Corstens, F. H. (1999a). Liposomes for scintigraphic detection of infection and infammation. Adv Drug Deliv Rev 37:225-235.
12. Laverman, P., Dams, E. T., Oyen, W. J., Storm, G., Koenders, E. B., Prevost, R., et al. (1999b). A novel method to label liposomes with 99mTc by the hydrazino nicotinyl derivative. J Nucl Med 40:192-197.
13. Li, L., Wartchow, C. A., Danthi, S. N., Shen, Z., Dechene, N., Pease, J., et al. (2004). A novel antiangiogenesis therapy using an integrin antagonist or anti-FLK-1 antibody-coated 90Y-labeled nanopar-ticles. Int J Radiat Oncol Biol Phys 58:1215-1227.
14. Lian, T., Ho, R. J. (2001). Trends and developments in liposome drug delivery systems. J Pharm Sci 90:667-680.
15. Mahmood, A., Jones, J. G. (2003). Thechnetium radiopharmaceuticals. In: Welch, M., Redvanly, C. S. (Eds.), Handbook of radiophar-maceuticals (pp 323-363). West Sussex, UK: John Wiley & Sons, Ltd.
16. McAfee, J. G., Takur, M. L. (1976). Survey of radioactive agents for in vitro labeling of phagocytic leukocytes. I. Soluble agents. J Nucl Med 17:480-487.
17. Meares, C. F., Moi, M. K., Diril, H., Kukis, D. L., McCall, M. J., Deshpande, S. V., et al. (1990). Macrocyclic chelates of radio-metals for diagnosis and therapy. Br J Cancer Suppl 10:21-26.
18. Richardson, V. J., Jeyasingh, K., Jewkes, R. F., Ryman, B. E., Tattersall, M. H. N. (1978). Possible tumor localization of Tc-99m-labeled liposomes: efects of lipid composition, charge, and liposome size. J Nucl Med 19:1049-1054.
19. Rofsky, N. M., Lee, V. S., Laub, G., Pollack, M. A., Krinsky, G. A., Tomasson, D., et al. (1999). Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 212:876-884.
20. Rolland, A., Collet, B., Le Verge, R., Toujas, L. (1989). Blood clearance and organ distribution of intravenously administered polymethacrylic nanoparticles in mice. J Pharm Sci 78:481-484.
21. Scherphof, G. L. (1985). Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupfer cells in vivo and in vitro. Ann N Y Acad Sci 446:368-384.
22. Stark, B., Debbage, P., Andreae, F., Mosgoeller, W., Prassl, R. (2007). Association of vasoactive intestinal peptide with polymer-grafted liposomes: structural aspects for pulmonary delivery. Biochim Biophys Acta 1768:705-714.
23. Torchilin, V. P. (2006). Multifunctional nanocarriers. Adv Drug Deliv Rev 58:1532-1555.
24. Torchilin, V. P., Lukyanov, A. N. (2003). Peptide and protein drug delivery to and into tumors: challenges and solutions. Drug Discov Today 8:259-266.
25. Torchilin, V. P. (2000). Polymeric contrast agents for medical imaging. Curr Pharm Biotechnol 1:183-215.
26. Torchlini, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 4:145-160.
27. Waibel, R., Alberto, R., Willuda, J., Finnern, R., Schibli, R., Stichelberger, A., et al. (1999). Stable one-step technetium-99m labelling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol 17:897-901.
28. Weiner, R. E., Takur, M. (2003). Chemistry of gallium and indium radiopharmaceuticals. In: Welch, M., Redvanly, C. S. (Eds.), Handbook of radiopharmaceuticals (pp 363-399). West Sussex, UK: John Wiley & Sons, Ltd.
29. Woltering, E., Mamikunian, P. M., Zeitz, S., Krutzik, S. R., Go, V. L. W., Vinik, A. I., et al. (2005). Octreotide acetate (LAR) dose efect on plasma octreotide levels: impact on neuroendocrine tumour management. J Clin Oncol 23:3177.